Loading data for TDACU — first visit, this takes a few seconds.
Translational Development... (TDACU)
NasdaqGM: TDACU
· Real-Time Price · USD
12.89
+0.00 (0.00%)
At close: Jul 28, 2026, 8:00 PM
Translational Development Acquisition Corp. (TDACU) Stock Price, Analysis & Data
0.00% (1D)
No data available
| Bid | n/a |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 5.54M |
| Beta | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| P/B (ttm) | -41.45 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | 18 |
| Avg. Volume (20D) | 845 |
| Open | 11.89 |
| Previous Close | 12.89 |
| Day's Range | 12.89 - 12.89 |
| 52-Week Range | 10.36 - 17.29 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About TDACU
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York....
Industry Shell Companies
Sector Financial Services
IPO Date Dec 23, 2024
Employees n/a
Stock Exchange NasdaqGM
Ticker Symbol TDACU
Financial Performance
In 2025, Translational Development Acquisition's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were 6.36M, a decrease of -9,059.65%.
Financial Statements